Linked Life Data

20034831

Source:http://linkedlifedata.com/resource/pubmed/id/20034831

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-2-3
pubmed:abstractText
To compare effectiveness, associated cost of outcomes and cost-effectiveness of a single annual infusion of zoledronic acid versus current treatment strategies plans for postmenopausal osteoporosis in France.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1778-7254
pubmed:author
pubmed:copyrightInfo
Copyright 2009. Published by Elsevier SAS.
pubmed:issnType
Electronic
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
53-7
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis.
pubmed:affiliation
Inserm ERI 12, service de rhumatologie, CHU d'Amiens, 1, place Victor-Pauchet, 80054 Amiens, France. fardellone.patrice@chu-amiens.fr
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't